Buscar resultados de ensayos clínicos
Alopecia Areata - 208 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Plaquenil for Alopecia Areata, Alopecia Totalis Condición: Alopecia Areata Fecha: 2005-09-12 Intervenciones: Drug: Hydroxychloroquine |
Terminated |
Nombre del estudio: A Study of Secukinumab for the Treatment of Alopecia Areata Condición: Alopecia Areata Fecha: 2015-11-04 Intervenciones:
|
Completed |
Nombre del estudio: Alefacept in Patients With Severe Scalp Alopecia Areata Condición: Alopecia Areata Fecha: 2005-09-09 Intervenciones: Drug: Alefacept Study participants will receive weekly IM administration of placebo or 15 mg of alefacep |
Active, not recruiting |
Nombre del estudio: Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis Condición: Alopecia Areata Fecha: 2014-11-14 Intervenciones: Drug: Tofacitinib Other Name: XELJANZ |
Active, not recruiting |
Nombre del estudio: Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata Condición: Alopecia Areata Fecha: 2016-02-11 Intervenciones:
|
Completed |
Nombre del estudio: Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin Condición: Alopecia Areata Fecha: 2006-12-05 Intervenciones: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units |
Withdrawn |
Nombre del estudio: Childhood Alopecia Areata Study Using the 308-nm Excimer Laser Condición: Alopecia Areata Fecha: 2012-11-01 Intervenciones:
|
Recruiting |
Nombre del estudio: Topical Garlic Concentrate for Alopecia Areata in Children Condición: Alopecia Areata Fecha: 2015-12-15 Intervenciones: Drug: garlic concentrate Topical application of GarlicRich gel on the scalp areas affected with alopecia |
Completed |
Nombre del estudio: Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata Condición: Alopecia Areata Fecha: 2013-09-23 Intervenciones: Drug: Ruxolitinib A fixed dose of ruxolitinib (20mg) will be self-administered orally twice daily for 12 |
Withdrawn |
Nombre del estudio: A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata Condición: Alopecia Areata Fecha: 2013-08-02 Intervenciones:
|